CD8 alpha Recombinant Rabbit Monoclonal Antibody [SI18-01]
Usd: 385 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1606-31_Europe.pdf
- No MSDS Found
Overview
Product Name
CD8 alpha Recombinant Rabbit Monoclonal Antibody [SI18-01]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human CD8 alpha aa 186-235 / 235.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, FC
Target Molecular Weight
Predicted band size: 26 kDa
Positive Control
THP-1 cell lysate, Jurkat cell lysate, PC-3M cell lysate, Hela, CRC, human spleen tissue, human lymph node tissue, human appendix tissue, Jurkat.
Conjugation
unconjugated
Clone Number
SI18-01
RRID
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
| WB | IF-Cell | IF-Tissue | IHC-P | FC | |
|---|---|---|---|---|---|
| Human |
|
|
|
|
|
| Mouse |
|
|
|
||
| Rat |
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IF-Cell
-
1:100-1:200
-
IF-Tissue
-
1:100-1:200
-
IHC-P
-
1:100-1:200
-
FC
-
1:500-1:1,000
Target
Function
The T cell receptor (TCR) is a heterodimer composed of either α and β or γ and δ chains. CD3 chains and the CD4 or CD8 (CD8-α and CD8-β) co-receptors are also required for efficient signal transduction through the TCR. The TCR is expressed on T helper and T cytotoxic cells that can be distinguished by their expression of CD4 and CD8 proteins; T helper cells express CD4 proteins and T cytotoxic cells display CD8 proteins. CD8s are cell surface glycoproteins that exist as two chain complex (αα or αβ) receptors that bind class I MHC molecules presented by the antigen-presenting cell (APC). A primary function of CD8 proteins is to facilitate antigen recognition by the TCR and to strengthen the avidity of the TCR-antigen interactions. An additional role for CD8-expressing T cells may be to maintain low levels of HIV expression.
Background References
1. Zehbe, I. et al. 2007. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer. J Immunother. 30: 523-532.
2. Morales, P.J. et al. 2003. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J. Immunology. 171: 6215-6224.
Tissue Specificity
CD8 on thymus-derived T-cells usually consists of a disulfide-linked alpha/CD8A and a beta/CD8B chain. Less frequently, CD8 can be expressed as a CD8A homodimer. A subset of natural killer cells, memory T-cells, intraepithelial lymphocytes, monocytes and dendritic cells expresses CD8A homodimers. Expressed at the cell surface of plasmacytoid dendritic cells upon herpes simplex virus-1 stimulation.
Post-translational Modification
Palmitoylated, but association with CD8B seems to be more important for the enrichment of CD8A in lipid rafts.; O-glycosylated.; Phosphorylated in cytotoxic T-lymphocytes (CTLs) following activation.
Subcellular Location
Cell membrane, Secreted.
UNIPROT
Synonyms
alpha polypeptide (p32) antibody
CD8 antibody
CD8 antigen alpha polypeptide antibody
CD8 antigen alpha polypeptide (p32) antibody
CD8a antibody
CD8A antigen antibody
CD8A molecule antibody
CD8A_HUMAN antibody
Leu2 antibody
Leu2 T lymphocyte antigen antibody
Expandalpha polypeptide (p32) antibody
CD8 antibody
CD8 antigen alpha polypeptide antibody
CD8 antigen alpha polypeptide (p32) antibody
CD8a antibody
CD8A antigen antibody
CD8A molecule antibody
CD8A_HUMAN antibody
Leu2 antibody
Leu2 T lymphocyte antigen antibody
Ly3 antibody
LYT3 antibody
MAL antibody
OKT8 T cell antigen antibody
OTTHUMP00000160760 antibody
OTTHUMP00000160764 antibody
OTTHUMP00000203528 antibody
OTTHUMP00000203721 antibody
p32 antibody
T cell antigen Leu2 antibody
T cell co receptor antibody
T-cell surface glycoprotein CD8 alpha chain antibody
T-lymphocyte differentiation antigen T8/Leu-2 antibody
T8 T cell antigen antibody
T8/Leu-2 T-lymphocyte differentiation antigen antibody
CollapseImages
-
Western blot analysis of CD8 alpha on different lysates with Rabbit anti-CD8 alpha antibody (ET1606-31) at 1/2,000 dilution.
Lane 1: THP-1 cell lysate
Lane 2: Jurkat cell lysate
Lane 3: PC-3M cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 26 kDa
Observed band size: 35 kDa
Exposure time: 2 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1606-31) at 1/2,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:100,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human spleen tissue using anti-CD8 alpha antibody.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-31, 1/100) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lymph node tissue with Rabbit anti-CD8 alpha antibody (ET1606-31) at 1/100 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-31) at 1/100 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human appendix tissue with Rabbit anti-CD8 alpha antibody (ET1606-31) at 1/100 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-31) at 1/100 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of THP-1 cells labeling CD8 alpha with Rabbit anti-CD8 alpha antibody (ET1606-31) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CD8 alpha antibody (ET1606-31) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of Jurkat cells labeling CD8 alpha.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1606-31, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Citation
-
TCF21 Downregulation Induces ERO1A Expression and Upregulates IDO1 to Trigger Immune Escape in Lung Adenocarcinoma
Journal: APMIS
DOI: 10.1111/apm.70094
IF: 2.6
Application: IHC
Reactivity: Mouse
Publish date: 2025 Nov
-
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07614-z
IF: 8.1
Application: IHC-P
Reactivity: Human,Mouse
Publish date: 2025 Apr
-
Synergistic approach to combating triple-negative breast cancer: ddr1-targeted antibody-drug conjugate combined with pembrolizumab
Journal: Journal Of Pharmaceutical Analysis
DOI:
IF: 6.1
Application: IF-cell
Reactivity: Human
Publish date: 2024 Sept
-
Machine learning-driven estimation of mutational burden highlights DNAH5 as a prognostic marker in colorectal cancer
Journal: Biology Direct
DOI:
IF: 5.7
Application: IHC-P
Reactivity: Human
Publish date: 2024 Nov
-
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy
Journal: Molecular Therapy
DOI:
IF: 12.4
Application: FC
Reactivity: Mouse
Publish date: 2023 Jul
-
Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells
Journal: Journal Of Translational Medicine
DOI:
IF: 7.4
Application: IF-cell
Reactivity: Human
Publish date: 2023 Jul
-
Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer
Journal: Frontiers In Immunology
DOI:
IF: 7.3
Application: IHC-P
Reactivity: Human
Publish date: 2023 Apr
-
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Journal: Molecular Cancer
DOI:
IF: 27.401
Application: IHC-P
Reactivity: Human
Publish date: 2022 Mar
-
Pyroptosis predicts immunotherapy outcomes across multiple cancer types
Journal: Clinical Immunology
DOI:
IF: 8.6
Application: IHC-P
Reactivity: Human
Publish date: 2022 Dec
-
Hypermutated tumours across 11 cancer types show three distinct immune subtypes
Journal: European Journal Of Cancer
DOI:
IF: 9.162
Application: IF-cell
Reactivity: Human
Publish date: 2021 May
-
Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Journal: International Journal Of Molecular Sciences
DOI:
IF: 4.183
Application: IHC-P,WB
Reactivity: Human
Publish date: 2019 Oct
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Products with the same target and pathway
CD8 alpha Mouse Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
CD8 alpha Recombinant Rabbit Monoclonal Antibody [PSH19-81]
Application: WB,IHC-P,IF-Tissue,mIHC,FC(Intra)
Reactivity: Human,Rat
Conjugate: unconjugated
CD8 alpha Recombinant Rabbit Monoclonal Antibody [PSH19-81] - BSA and Azide free
Application: WB,IHC-P,IF-Tissue,FC(Intra)
Reactivity: Human,Rat
Conjugate: unconjugated
CD8 alpha Recombinant Rabbit Monoclonal Antibody [SI18-01] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated